Why buy this market study?

80% of managers consider sector information as essential in decision-making; a growing practice. Decision-makers who do not consult market studies may therefore disadvantage their project. At Businesscoot, we offer synthetic and visual market studies. These studies include the information necessary for a good understanding of a sector.

What payment methods are available?

4 payment solutions are offered: Credit card payment, Payment via Paypal, Bank transfer payment, Deferred payment by sending a purchase order to info@businesscoot.com

What are the terms of the Satisfied or Money Back guarantee?

If you consider that the content of the study is insufficient in relation to its price, we will refund you if the following conditions are met: The purchase is made as a professional, with a SIRET number, an address and a professional email. The refund request is sent to info@businesscoot.com within the week following the order.

Is it possible to subscribe to access all studies?

Yes. Contact us at info@businesscoot.com so we can define together the subscription formula best suited to your needs.

Health

The in vitro diagnostics market - France

An analysis with all the essential information for a clear, complete and quantified view of this market.

Available in French

The in vitro diagnostics market - France

Innovation

Unlimited questions for 24h

SectorAI — Query French markets. Access the data that makes the difference.

Ask the questions you care about on any market — including niche or emerging ones.

Get reliable answers built from private professional content, inaccessible to generalist AIs (GPT, Gemini, Mistral, etc.).

Study Overview

In-vitro diagnostics ( IVD) covers all the techniques, devices and equipment used on human or animal tissue samples or biological fluids to diagnose pathologies in medical laboratories. In vitro din vitro diagnostics therefore differs from in vivo diagnostics, which are performed directly on living organisms and not on samples taken from them.and not on samples taken from them. More specifically, the european Union regulation 2017/746defines an in vitro diagnostic device (IVD) as "any medical device which consists of a reagent, reagent product, calibration material, control material, kit, instrument, apparatus, equipment, software or systemused alone or in combination, intended by the manufacturer to be used in vitro in the examination of samples from the human body, including donated blood and tissue, solely or principally for the purpose of providing information on one or more of the following:

concerning a physiological or pathological process or state; concerning congenital physical or mental deficiencies; concerning the predisposition to a condition or disease; to determine whether a given treatment is safe for and compatible with potential recipients; to predict response or reactions to a treatment; to define or control therapeutic measures ".

The main customers of in vitro diagnostics manufacturers are medical laboratories and hospital laboratories. The global in vitro diagnostics market is growing, and is set to continue to do so in the years ahead. In fact, it is estimated to reach $94.7 billion in 2022, after increasing by 80% since 2018, and should reach $157 billion in 2030. The CAGR (average annual growth rate) over the period 2023-2030 would be 7. 1%[pwc] This market is largely dominated by North America(42.8% share in 2020), followed by Europe and Asia-Pacific[pwc]. The latter region, however, is experiencing the most dynamic growth, with a record CAGR forecast for the period 2023-2030 [Fortune Business Insights], while it was already estimated at 8.6% between 2020 and 2024. [pwc] The French IVD market is Europe's second-largest (12.6% share in 2021) , behind Germany. While showed moderate growth until 2019, following a period of consolidation and concentration in the sector through numerous takeovers and mergers between laboratories, the explosion in demand for Covid-19 screening tests has boosted the market in 2020 and 2021. Indeed, sales in 2020 and 2021 grew by 32% and 22% respectively, with the French IVD market reaching a value of €2.61 billion in 2021 . [Medtech]

Key takeaways

Growth and sector challenges
Demand analysis
Market structure and organization
Supply and pricing analysis
Player segmentation
Latest trends and innovations

Methodology

Our methodology

Our method combines human expertise and a large corpus of sources, including exclusive and private data, for optimal understanding of the sector

Broad source base

• National, international, and private databases
• Professional press and polling institutes
• Industry reports, company financial statements...

Exclusive data

• Indexpresse sectoral database
• Preferred Brands database
• Expert interviews and proprietary indicators

Human expertise

• Experienced research analysts
• Know-how developed through 1500+ studies
• In-depth and rigorous analysis

Visual and actionable reports

• Graphic studies with synthetic structure
• Downloadable data
• Link to original sources

Contents

Sommaire

1. Market overview
- 1.1 Overview and definition of the in vitro diagnostics market
- 1.2 A fast-growing global market
- 1.3 A major French market
- 1.4 The COVID-19 crisis accelerated IVD consumption
2. Demand analysis
- 2.1 Healthcare expenditure in the EU
- 2.2 Medical biology laboratories in the consumption of healthcare and medical goods
- 2.3 Demographic trends and changing consumption patterns
- 2.4 Strong demand for Covid-19
3. Market structure
- 3.1 A consolidating domestic market
- 3.2 Reagent manufacturing at the heart of the in vitro diagnostics market
- 3.3 Distribution of IVD devices: financial risks borne by suppliers
4. Offer analysis
- 4.1 The in vitro diagnostics offering, by pathology
- 4.2 Breakdown of medical biology expenditure by pathology: a range of diagnostics
5. Regulations
- 5.1 A national market subject to evolving European regulations